Phreesia, Inc. (NYSE:PHR) saw a recent sale of shares by company insider David Linetsky, who serves as the Senior Vice President of Life Sciences. According to a new filing with the Securities and Exchange Commission, Linetsky disposed of 2,212 shares of common stock on April 15, at a weighted average price of $22.8574, totaling over $50,560.
The sale occurred in a range of prices from $22.63 to $23.06 per share. The transactions were executed in multiple parts and were part of a non-discretionary transaction pursuant to the company's mandatory sell-to-cover policy. This policy is commonly used to satisfy tax withholding obligations that arise upon the settlement of restricted stock units.
After the sale, Linetsky's direct holdings in Phreesia, Inc. amount to 204,038 shares. Additionally, it was noted that there are 7,356 shares owned indirectly by his spouse. The SEC filing included a footnote clarifying that Linetsky is willing to provide full information regarding the number of shares sold at each separate price within the reported range, upon request.
Investors often monitor insider transactions as they can provide insights into how the company's top executives view the stock's value and future prospects. Shares of Phreesia, Inc. are publicly traded and can be followed for price updates and further transactions.
InvestingPro Insights
Phreesia, Inc. (NYSE:PHR) has been navigating the market with a mix of challenges and growth. A key metric to consider is the company's market capitalization, which currently stands at $1.31 billion. Despite not being profitable over the last twelve months, Phreesia has demonstrated significant revenue growth, with a 26.84% increase as of Q4 2024, highlighting its potential to expand its market share and financial scale.
One of the InvestingPro Tips suggests that Phreesia operates with a moderate level of debt, which could be a strategic financial management choice, allowing the company to invest in growth while managing its liabilities. Additionally, the company's stock has seen a large price uptick over the last six months, boasting a 36.74% return, signaling a potential investor confidence in its future trajectory.
However, investors should note that analysts do not anticipate the company will be profitable this year, and Phreesia does not pay a dividend to shareholders. These factors may influence investment decisions depending on individual risk appetites and investment strategies. For those interested in a deeper analysis, InvestingPro offers additional tips for Phreesia, Inc., which can be accessed by visiting: https://www.investing.com/pro/PHR. There are a total of 5 more InvestingPro Tips available, providing a comprehensive outlook for more informed decision-making.
To further support investment research, the InvestingPro platform offers real-time metrics such as the P/E Ratio, currently at -9.22, and a Price / Book ratio of 5.14 as of Q4 2024. These metrics can help investors gauge the company's valuation and financial health. For those interested in subscribing to InvestingPro, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking access to a vast array of financial tools and insights.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.